As such, it is pertinent to consider or add anti-obesity medications as adjunct to lifestyle therapy in people with weight-related complications (including uncontrolled diabetes), those who have difficulties losing weight with lifestyle therapy, or who have experienced weight regain following initial success on lifestyle therapy alone [19]
Policy Changes Influencing Wegovy and Other Medications Beyond corporate rivalry, the government is playing an increasing role in influencing the weight loss drug price drop 2025 , signaling a long-term commitment to making these treatments part of standard chronic care
Traditional Uses of GLP-1s Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications that were initially prescribed to treat type 2 diabetes
To determine whether diabetes is the cause of chronic kidney disease, healthcare providers can perform a kidney biopsy, although this procedure isnt as common as other diagnostic tests
It should only be prescribed for treatment of type 2 diabetes.